Technical Analysis for PLXP - PLx Pharma Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
4.7388 | -0.97% | -0.05 |
PLXP closed down 0.97 percent on Friday, January 17, 2020, on 9 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| Historical PLXP trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Sell Signal | Bearish | 0.00% | |
| 50 DMA Support | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| BB Squeeze Started | Range Contraction | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | -0.97% | |
| Narrow Range Bar | Range Contraction | -0.97% | |
| Inside Day | Range Contraction | -0.97% | |
| Overbought Stochastic | Strength | -0.97% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | -1.53% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/08/2019
- Sector: Healthcare
- Industry: Biotechnology
PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325 mg, PL1100/PL1200 Ibuprofen. PLxGuard delivery system uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs to selectively release these drugs to targeted portions of the GI tract. The Company’s lead product Aspertec 325 mg is a liquid-fill aspirin capsule for prevention of cardiovascular disease. Through PLxGuard delivery system the Company creates a lipid-based formulation of ibuprofen, PL1200 Ibuprofen Capsules, 200 mg.
Biopharmaceutical Drugs Organic Compounds Cardiovascular Disease Analgesics Hepatotoxins Carboxylic Acids Ibuprofen
Biopharmaceutical Drugs Organic Compounds Cardiovascular Disease Analgesics Hepatotoxins Carboxylic Acids Ibuprofen
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.3 |
| 52 Week Low | 3.25 |
| Average Volume | 11,719 |
| 200-Day Moving Average | 5.26 |
| 50-Day Moving Average | 4.60 |
| 20-Day Moving Average | 4.59 |
| 10-Day Moving Average | 4.68 |
| Average True Range | 0.28 |
| ADX | 46.08 |
| +DI | 11.71 |
| -DI | 28.32 |
| Chandelier Exit (Long, 3 ATRs ) | 4.07 |
| Chandelier Exit (Short, 3 ATRs ) | 4.08 |
| Upper Bollinger Band | 4.90 |
| Lower Bollinger Band | 4.27 |
| Percent B (%b) | 0.74 |
| BandWidth | 13.90 |
| MACD Line | 0.05 |
| MACD Signal Line | 0.01 |
| MACD Histogram | 0.0384 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.05 | ||||
| Resistance 3 (R3) | 5.04 | 4.92 | 5.00 | ||
| Resistance 2 (R2) | 4.92 | 4.84 | 4.93 | 4.98 | |
| Resistance 1 (R1) | 4.83 | 4.79 | 4.77 | 4.84 | 4.97 |
| Pivot Point | 4.71 | 4.71 | 4.68 | 4.72 | 4.71 |
| Support 1 (S1) | 4.62 | 4.63 | 4.56 | 4.63 | 4.51 |
| Support 2 (S2) | 4.50 | 4.58 | 4.51 | 4.49 | |
| Support 3 (S3) | 4.41 | 4.50 | 4.48 | ||
| Support 4 (S4) | 4.42 |
